vTv Therapeutics Inc (NASDAQ:VTVT)
| 1.51 Delayed Data As of 3:59pm ET |  +0.01 / +0.67%Today’s Change | 1.00 Today|||52-Week Range 3.50 | -43.02% Year-to-Date |
Latest VTVT News | Press Releases
No recent news for vTv Therapeutics Inc.
Today’s Trading
| Previous close | 1.50 |
| Today’s open | 1.50 |
| Day’s range | 1.50 - 1.55 |
| Volume | 148,502 |
| Average volume (3 months) | 260,394 |
| Market cap | $89.3M |
Data as of 3:59pm ET, 12/10/2019
Growth & Valuation
| Earnings growth (last year) | +58.40% |
| Earnings growth (this year) | +36.23% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +4,172.85% |
| P/E ratio | NM |
| Price/Sales | 2.65 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Union Asia Enterpris... | 0.00 | 0.00% |
| --Kirin Group Holdings... | +0.01 | +1.49% |
| ---- | ||
| ---- |
Data as of 12/10/2019
Financials
| Next reporting date | March 3, 2020 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $12.4M |
| Annual profit (last year) | -$8.7M |
| Net profit margin | -69.57% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters High Point, North Carolina |
Forecasts
